Sept 24 (Reuters) - Neucyte Inc:
* NEUCYTE INC - ENTERED INTO EXCLUSIVE LICENSE AGREEMENT WITH TRILLIUM THERAPEUTICS
* NEUCYTE, INC - AGREEMENT TO ADVANCE UNDISCLOSED PRECLINICAL COMPOUND FOR TREATMENT OF REFRACTORY EPILEPSY AND RELATED NEUROLOGICAL DISORDERS
* NEUCYTE, INC - UNDER TERMS OF AGREEMENT, TRILLIUM HAS GRANTED NEUCYTE EXCLUSIVE, WORLDWIDE RIGHTS TO DEVELOP AND COMMERCIALIZE COMPOUND